Impact of residual disease biomarkers on the prognosis of HER2-positive breast cancer following neoadjuvant therapy.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer medicine"
DOI: 10.1002/cam4.5839
Abstract: The changes in prognostic factors and clinicopathological characteristics of residual disease following neoadjuvant therapy (NAT) for breast cancer are important references for postoperative adjuvant therapy. The analyses of the relationship between the clinicopathological characteristics of… read more here.
Keywords: residual disease; breast cancer; cancer; following neoadjuvant ... See more keywords
Factors associated with pathologic complete response following neoadjuvant chemoradiation and esophagectomy for carcinoma of esophagus and gastroesophageal junction
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27103
Abstract: The aim of this study was to analyze factors associated with pathologic complete response (pCR) following neoadjuvant chemoradiation (NCRT) and esophagectomy for carcinoma of the esophagus (EC) and gastroesophageal junction (GEJ). read more here.
Keywords: following neoadjuvant; complete response; factors associated; neoadjuvant chemoradiation ... See more keywords
Clinical features and risk factors for early recurrence after esophagectomy following neoadjuvant chemotherapy for esophageal cancer
Sign Up to like & getrecommendations! Published in 2021 at "Surgery Today"
DOI: 10.1007/s00595-021-02397-0
Abstract: The purpose of this study was to clarify the clinical features and outcomes of patients with recurrence after esophagectomy following neoadjuvant chemotherapy (NAC) related to the timing of recurrence. We reviewed 240 consecutive patients who… read more here.
Keywords: early recurrence; clinical features; recurrence; recurrence esophagectomy ... See more keywords
Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy
Sign Up to like & getrecommendations! Published in 2020 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-020-05563-z
Abstract: Purpose Women with residual invasive breast cancer at the primary site or axillary lymph nodes following neoadjuvant chemotherapy have a high risk of recurrence. Eribulin improves survival in patients with metastatic breast cancer who progress… read more here.
Keywords: eribulin; neoadjuvant chemotherapy; following neoadjuvant; breast cancer ... See more keywords
Factors Associated With Surgical Modality Following Neoadjuvant Chemotherapy in Patients with Breast Cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical breast cancer"
DOI: 10.1016/j.clbc.2021.03.011
Abstract: BACKGROUND The breast-conserving surgery (BCS) rate for patients with breast cancer in China is much lower than that in Europe and the United States. This study aimed to identify factors affecting the choice of surgical… read more here.
Keywords: surgical modality; patients breast; modality following; following neoadjuvant ... See more keywords
Thoracoscopic versus open surgery following neoadjuvant chemoradiation for clinical N2 lung cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Seminars in thoracic and cardiovascular surgery"
DOI: 10.1053/j.semtcvs.2021.01.002
Abstract: OBJECTIVE We evaluated the feasibility of video-assisted thoracoscopic surgery (VATS) following neoadjuvant concurrent chemoradiotherapy (nCCRT) for N2 non-small cell lung cancer (NSCLC). METHODS We retrospectively reviewed patients with clinical N2 NSCLC who underwent lobectomy and… read more here.
Keywords: surgery; thoracoscopic; group; following neoadjuvant ... See more keywords
Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Sign Up to like & getrecommendations! Published in 2019 at "Acta Oncologica"
DOI: 10.1080/0284186x.2019.1566775
Abstract: Abstract Purpose: We evaluate the effect of an exercised prehabilitation programme on tumour response in rectal cancer patients following neoadjuvant chemoradiotherapy (NACRT). Patients and Methods: Rectal cancer patients with (MRI-defined) threatened resection margins who completed… read more here.
Keywords: regression; rectal cancer; following neoadjuvant; week ... See more keywords
An International Cohort Study of Prognosis Associated With Pathologically Complete Response Following Neoadjuvant Chemotherapy Versus Chemoradiotherapy of Surgical Treated Esophageal Adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Surgery"
DOI: 10.1097/sla.0000000000005619
Abstract: Objective: To compare overall (OS) and recurrence-free survival (RFS) in esophageal adenocarcinoma patients with a pathologically complete response (pCR) following neoadjuvant chemotherapy (nCT) or neoadjuvant chemoradiotherapy (nCRT). Background: In the absence of survival differences in… read more here.
Keywords: chemoradiotherapy; following neoadjuvant; international cohort; cohort study ... See more keywords
Can normalized carcinoembryonic antigen following neoadjuvant chemoradiation predict tumour recurrence after curative resection for locally advanced rectal cancer?
Sign Up to like & getrecommendations! Published in 2021 at "Colorectal Disease"
DOI: 10.1111/codi.15583
Abstract: The aim of this work was to evaluate whether normalized carcinoembryonic antigen (CEA) following neoadjuvant chemoradiation predicts the prognosis following curative resection in locally advanced rectal cancer. read more here.
Keywords: following neoadjuvant; neoadjuvant chemoradiation; normalized carcinoembryonic; carcinoembryonic antigen ... See more keywords
Abstract 1148: Multimodal spatial transcriptomics and proteomics analysis of the resectable NSCLC ecosystem following neoadjuvant chemoimmunotherapy
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Research"
DOI: 10.1158/1538-7445.am2024-1148
Abstract: Neoadjuvant and perioperative immunotherapy with checkpoint inhibitors (ICIs), combined with chemotherapy (CT), have improved outcomes for patients with resectable non-small cell lung cancer (NSCLC). Pathologic tumor response has been utilized in clinical trials as a… read more here.
Keywords: spatial transcriptomics; multimodal spatial; analysis; response ... See more keywords
Response-adaptive resection following neoadjuvant penpulimab combined with chemotherapy in HPV-negative operable locally advanced head and neck squamous cell: A phase II clinical trial.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e18046
Abstract: e18046 Background: In the traditional chemotherapy paradigm, Surgical resection was tailored to the tumor's pre-treatment dimensions. Neoadjuvant immunochemotherapy has demonstrated higher remission rates and more profound tumor regression, suggest a substantial reduction in necessary surgical… read more here.
Keywords: clinical trial; resection; response; following neoadjuvant ... See more keywords